Hypocholesterolemia in haematologic malignancies;Hipocolesterolemia en neoplasias hematológicas

Sangre

Volumn 42, Issue 1, 1997, Pages 7-10

  Aixalá, Mónica ^a,b   Sarandría, Cecilia Noemí ^a   Speroni, Javier Guillermo ^a  

^a División Laboratorio   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; BLOOD DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED;

EID: 0031062742     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jacobs D, Higgins M, Reed D, Iso H, Mc Millan G. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation 1992; 86:1046-1060.
2. Marenah C, Lewis B, Hassall D, La Vlle A, Cortese C, Mitchell W, et al. Hypocholesterolaemia and non-cardiovascular disease: metabolic studies on subjects with low plasma cholesterol concentrations. Br Med J 1983; 286: 1603-1606.
3. Nomura AM, Stemmermann GN, Chyou PH. Prospective study of serum cholesterol levels and large bowel cancer J Natl Cancer Inst 1991, 83: 1403-1407.
4. Nydegger U, Butler R. Serum lipoprotein levels in patients with cancer. Cancer Res 1972; 32: 1756-1760.
5. Sherwin R, Wentworth D, Cutler J, Hulley S, Kuller L, Stamler J. Serum cholesterol levels and cancer mortality in 361 662 men screened for the multiple risk factor intervention trial JAMA 1987; 257: 943-948.
6. Tomberg S, Holm L, Carstensen J, Eklund G. Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst 1989; 81: 1917-1921.
7. Swanson C, Potischman N,Barrett R, Berman M, Mortel R,Twiggs L, et al. Endometrial cancerrisk in relation to serum lipids and lipoproteins levels.Cancer Epidemiol Biomarkers Prev 1994; 3: 575-581
8. Vitols S, Gahrton G, Bjorkholm M, Peterson C. Hypocholesterolaemia in malignancy due to elevated low density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet 1985; 1150-1154.
9. Muller C, Wagner A, Maucher C, Steinke B. Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemia. Eur J Haematol 1989; 43: 235-239.
10. Gmsberg H, Gilbert H, Gibson J, Le N, Brown V. Increased lowdensity-lipoprotein catabolism in myeloproliferative disorders. Ann Intern Med 1982; 96: 311-316.
11. Cucuianu A, Malide D, Petrov L, Patiu M, Vlaicu S, Cucuianu M. Serum cholesterol and apolipoprotein B levels and serum cholinesterase activity in selected hematologic malignancies. Rom J Intern Med 1992; 30:261-268.
12. Ortega Calvo M, Mendez Mora JL, Fabiani Romero F, Mellado Fuentes F. Hipocolesterolemia e hipoapolipoproteincmia A1 en una paciente diagnosticada de leucemia linfoblástica. Rev Clin Esp 1993; 193: 216-217.
13. Baroni S, Scribano D, Pagano L, Zuppi C, Leone G, Giardina B. Lipids and lipoproteins in acute lymphoblastic leukaemia (ALL) Leuk Res 1994; 18: 643-644.
14. Lorenc J, Kozak-Michalowska I, Polkowska-Kulesza E. Disorders of lipids and iipoprotein metabolism in patients with chronic lymphocytic leukemia 1. Preliminary evaluation of lipemia and HDL fractions in various stages of the disease. Przegl-Lek 1989; 46: 713-718 .
15. Budd D, Ginsberg H. Hypocholesterolemia and acute myelogenous leukemia. Cancer 1986; 58:1361-1365.
16. Ettinger WH Jr, Su WH, Binkley N, Kouba E, Ershler W. Interleukin 6 causes hypocholesterolemia in middle-aged and old mesus monkeys. J Gerontol A Biol Sci Med Sci 1995; 50: M137-140.
17. Ettinger WH, Varma VK, Sorci-Thomas M, Parks JS, Sigmon RC, Smith TK, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler Thromb 1994; 14: 8-13.
18. Hermus AR, Sweep CG, Demacker PN, van der Meer MJ, Kloppenborg PW, van der Meer JW. Continues infusion of interleukin-1 beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides.Arteriocier Thromb 1992; 12: 1036-1043.
19. Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet 1992; 339; 1154-1156.
20. Inbar M, Ben-Bassat H.Fluidity difference in the surface membrane lipid core of human lymphoblastoid and lymphoma cell lines. Int J Cancer 1976; 18: 293-297.
21. Hachem H, Favre G, Reynal G, Soula G. Plasma lipoproteins and multiple myeloma. Variations of lipid constituents of HDL and apolipoproteins A1 and B. Ann Biol Clin Paris 1983; 41: 181-185.
22. Hachem H, Favre G, Ghalim N, Puchois P, Fruchart J, Soula G. Quantitative abnormalities of lipoprotein particles in multiple myeloma. J Clin Chem Clin Biochem 1987,25: 675-679.
23. Levy Y, Aviram M, Spira G, Tatarsky I, Brook GJ, Carter A. Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies. Postgrad Med J 1984; 60: 449-453.
24. Moorby CD, Gherardi E, Dovey L, Godliman C, Bowyer DE. Transforming growth factor-beta 1 and interleukin-1 beta stimulate LDL receptor activity en Hep G2 cells. Atherosclerosis 1992; 97: 21-28.